Zarazuela Zolkipli-Cunningham, MBChB, MRCP

faculty photo
Assistant Professor of Pediatrics (Human Genetics) at the Children's Hospital of Philadelphia
Attending Physician, Mitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia
Clinical Research Director, Mitochondrial Medicine Frontier Program, Division of Human Genetics, Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
6th Floor, Colket Translational Research Building
3501 Civic Center Boulevard
Philadelphia, PA 19104
Office: 2674264961
Education:
MBChB
Edinburgh University Medical School, Scotland, UK, 1996.
MRCPCH
Royal College of Physicians, Edinburgh, Scotland, 1999.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Mitochondrial Myopathy diagnosis and management
Percutaneous Muscle Needle Biopsy
Mitochondrial Disease
Neuromuscular
Muscle

Description of Research Expertise

Mitochondrial Myopathy outcome measures
Mitochondrial Myopathy exercise testing
Mitochondrial Myopathy clinical trials
Neuromuscular
Myopathy
Mitochondria
Muscle
Exercise
Spinal Muscular Atrophy
Nanosensor
Muscle Oxygen
Leigh syndrome
Longitudinal Studies

Selected Publications

Zolkipli-Cunningham Z, Flickinger J, Martin I, Santos JD, Balance E, Wellik A, Liebman M, Vishnubhatt S, Peterson P, Intarachumnum ND, Tindall A, McCormick E, Muraresku C, Bogush E, MacMullen L, Stanley K, Nguyen S, Goldstein A, Falk MJ, McDermott M, Xiao R: Natural History of Mitochondrial Disease Objective Measures reveals slow, progressive decline. Mitochondrial Medicine – Therapeutic Development 2024 conference, Hinxton UK March 2024 Notes: Scope: International. Notes: Poster and Pitch talk.

Flickinger J, Santos HD, Ballance E, Martin I, Intarachumnum ND, Xiao R, Zolkipli Cunningham Z: Validation of the Mitochondrial Myopathy Function Scale. Mitochondrial Medicine – Therapeutic Development 2024 conference, Hinxton, UK March 2024 Notes: Scope: International. Notes: Poster and Pitch talk

Wolfe A, Stimpson G, Ramsey D, Coratti G, Young SD, Mayhew A, Pane M, Rohwer A, Lofra RM, Duong T, O'Reilly E, Milev E, Civitello M, Sansone VA, D'Amico A, Bertini E, Messina S, Bruno C, Albamonte E, Mazzone E, Main M, Montes J, Glanzman AM, Zolkipli-Cunningham Z, Pasternak A, Marini-Bettolo C, Day JW, Darras BT, De Vivo DC, Baranello G, Scoto M, Finkel RS, Mercuri E, Muntoni F; international SMA consortium (iSMAc): Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Journal of Neuromuscular Disease February 2024 Notes: doi: 10.3233/JND-230211.

MacMullen L, George-Sankoh I, Stanley K, McCormick EM, Muraresku CC, Goldstein A, Zolkipli-Cunningham Z, Falk MJ: Bridging the Clinical-Research Gap: Harnessing an electronic data capture, integration, and visualization platform to systematically assess prospective patient-reported outcomes in mitochondrial medicine   Molecular Genetics and Metabolism February 2024 Notes: Accepted February 2024.

Trucco F, Ridout D, Weststrate H, Scoto M, Rohwer A, Coratti A, Main M, Mayhew A, Montes J, Sanctis RD, Pane M, Pera MC, Sansone VA, Albamonte E, D’Amico A, Bruno C, Messina S, Childs AM, Willis T, Ong M, Servais L, Majumdar A, Hughes I, Marini-Bettolo C, Parasuraman D, Gowda V, Baranello G, Bertini E, De Vivo DC, Darras B, Day JD, Mayer OH, Zolkipli-Cunningham Z, Finkel RS, Mercuri E, Muntoni F,on behalf of the iSMAC group: Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients with Spinal Muscular Atrophy Type 2 and Non-Ambulant Type 3. Neurology Clinical Practice 2024 Notes: Accepted March, 2024.

DiVito D, Wellik A, Burfield J, Peterson J, Flickinger J, Tindall A, Albanowski K, Vishnubhatt S, MacMullen L, Martin I, Muraresku C, McCormick E, George-Sankoh I, McCormack S, Goldstein A, Ganetzky R, Yudkoff M, Xiao R, Falk MJ, Mascarenhas MR, Zolkipli-Cunningham Z: Optimized Nutrition in Mitochondrial Disease Correlates to Improved Muscle Fatigue, Strength, and Quality of Life. Neurotherapeutics September 2023 Notes: https://doi.org/10.1007/s13311-023-01418-9.

Glanzman AM, Pasternak A, McDermott MP, Montes J, Coratti G, Young SD, Duong T, Martens WB, Day JW, Zolkipli-Cunningham Z, Sansone VA, D'Amico A, Messina S, Bruno C, Mercuri E, De Vio DC, Darras BT: The SMA Functional Composite Scope (SMA-FC) Updates with Inclusion of Longitudinal Data Pre and Post Imitation of Nusinersen CureSMA Annual SMA Research & Clinical Care Meeting, Orlando, FL July 2023 Notes: Poster.

Diodato D, Schiff M, Cohen BH, Bertini E, Rahman S, Workshop participants.: 258th ENMC International Workshop Leigh Syndrome Spectrum Genetic Causes, Natural History and Preparing for Clinical Trials. Neuromuscular Disorders 33(8): 700-709, June 2023 Notes: Workshop participant.

Flickinger J, Martin I, Santos JD, Nattapat Intarachumnum, Xiao R, Zolkipli-Cunningham Z: Mitochondrial Mobility Performance Levels. United Mitochondrial Disease Foundation Annual Meeting, Charlotte, NC June 2023 Notes: Poster

Flickinger J, Santos JD, Ballance E, Martin I, Nattapat Intarachumnum, Xiao R, Zolkipli-Cunningham Z: Validation of the Mitochondrial Myopathy Function Scale. United Mitochondrial Disease Foundation Annual Meeting, Charlotte, NC June 2023 Notes: Poster

back to top
Last updated: 03/27/2024
The Trustees of the University of Pennsylvania